Cargando…

Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution

PURPOSE: To analyze initial recurrence patterns in patients with newly diagnosed glioblastoma after radiotherapy plus concurrent and adjuvant temozolomide, and to investigate cumulative recurrence patterns after salvage treatment, including surgery, stereotactic radiotherapy, and chemotherapy. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogura, Kengo, Mizowaki, Takashi, Arakawa, Yoshiki, Ogura, Masakazu, Sakanaka, Katsuyuki, Miyamoto, Susumu, Hiraoka, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643853/ https://www.ncbi.nlm.nih.gov/pubmed/24499582 http://dx.doi.org/10.1186/1748-717X-8-97

Ejemplares similares

Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control
por: Ogura, Kengo, et al.
Publicado: (2013)

Long-term complications of definitive chemoradiotherapy for esophageal cancer using the classical method
por: Ito, Hitoshi, et al.
Publicado: (2017)

Effect of long fasting on myocardial accumulation in (18)F-fluorodeoxyglucose positron emission tomography after chemoradiotherapy for esophageal carcinoma
por: Ishida, Yuichi, et al.
Publicado: (2018)

Therapy-Related Acute Myeloid Leukemia 2 Months after Chemoradiotherapy for Esophageal Cancer: A Case Report
por: Hiraoka, Shinya, et al.
Publicado: (2020)

Non-coplanar volumetric-modulated arc therapy (VMAT) for craniopharyngiomas reduces radiation doses to the bilateral hippocampus: a planning study comparing dynamic conformal arc therapy, coplanar VMAT, and non-coplanar VMAT
por: Uto, Megumi, et al.
Publicado: (2016)

Dosimetric advantages of O‐ring design radiotherapy system for skull‐base tumors
por: Ogura, Kengo, et al.
Publicado: (2014)

A Case Report of Locally Advanced Anal Cancer with Solitary Cutaneous Nodular Metastasis in the Ipsilateral Labia Majora Treated with Definitive Chemoradiotherapy
por: Sakanaka, Katsuyuki, et al.
Publicado: (2019)

Assessment of interfractional prostate motion in patients immobilized in the prone position using a thermoplastic shell
por: Ikeda, Itaru, et al.
Publicado: (2014)

Apatinib Plus Temozolomide: An Effective Salvage Treatment for Recurrent Glioblastoma
por: Ge, Jingjing, et al.
Publicado: (2021)

Nutritional and clinical outcomes of chemoradiotherapy for clinical T1N0M0 esophageal carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2019)

Association of Chemoradiotherapy With Thoracic Vertebral Fractures in Patients With Esophageal Cancer
por: Fujii, Kota, et al.
Publicado: (2020)

Preoperative chemoradiotherapy for locally advanced low rectal cancer using intensity-modulated radiotherapy to spare the intestines: a single-institutional pilot trial
por: Sakanaka, Katsuyuki, et al.
Publicado: (2021)

Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors
por: Narabayashi, Masaru, et al.
Publicado: (2012)

Retrospective Analysis of Bevacizumab in Combination with Ifosfamide, Carboplatin, and Etoposide in Patients with Second Recurrence of Glioblastoma
por: Arakawa, Yoshiki, et al.
Publicado: (2013)

Differences in the dose–volume metrics with heterogeneity correction status and its influence on local control in stereotactic body radiation therapy for lung cancer
por: Ueki, Nami, et al.
Publicado: (2013)

Dosimetric comparison between dual-isocentric dynamic conformal arc therapy and mono-isocentric volumetric-modulated arc therapy for two large brain metastases
por: Uto, Megumi, et al.
Publicado: (2018)

GCT-50. LONG-TERM OUTCOMES OF INTRACRANIAL GERMINOMA IN A SINGLE INSTITUTION
por: Yamamoto, Etsuko, et al.
Publicado: (2020)

Optimal managements of elderly patients with glioblastoma
por: Arakawa, Yoshiki, et al.
Publicado: (2022)

ET-02 EFFICACY OF THE SALVAGE THERAPY VIA LOMUSTINE AND NIMUSTINE FOR RECURRENT GLIOBLASTOMA WITH TEMOZOLOMIDE RESISTANCE
por: Yamamuro, Shun, et al.
Publicado: (2019)

The Definition and Delineation of the Target Area of Radiotherapy Based on the Recurrence Pattern of Glioblastoma After Temozolomide Chemoradiotherapy
por: Zheng, Lin, et al.
Publicado: (2021)

Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results
por: Oike, Takahiro, et al.
Publicado: (2013)

Dosimetric advantages and clinical outcomes of simultaneous integrated boost intensity-modulated radiotherapy for anal squamous cell carcinoma
por: Sakanaka, Katsuyuki, et al.
Publicado: (2017)

Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
por: Roh, Tae Hoon, et al.
Publicado: (2020)

Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment
por: Darmon, Ilan, et al.
Publicado: (2017)

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017)

Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group
por: AOKI, Tomokazu, et al.
Publicado: (2017)

Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report
por: Sakanaka, Katsuyuki, et al.
Publicado: (2020)

Radiation-induced cystic brain necrosis developing 10 years after linac-based stereotactic radiosurgery for brain metastasis
por: Aizawa, Rihito, et al.
Publicado: (2018)

Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
por: Gwak, Ho-Shin, et al.
Publicado: (2013)

Temozolomide chronotherapy in patients with glioblastoma: a retrospective single-institute study
por: Damato, Anna R, et al.
Publicado: (2021)

Temozolomide as salvage treatment in primary brain lymphomas
por: Reni, M, et al.
Publicado: (2007)

Salvage treatment after definitive chemoradiotherapy for esophageal squamous cell carcinoma
por: Yagi, Koichi, et al.
Publicado: (2021)

Recurrence-free survival and prognosis after adjuvant therapy with radioactive iodine-131 in patients with differentiated thyroid carcinoma
por: Iizuka, Yusuke, et al.
Publicado: (2023)

Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy
por: Uto, Megumi, et al.
Publicado: (2021)

Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy
por: Choi, Seo Hee, et al.
Publicado: (2017)

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017)

Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
por: Lim, Michael, et al.
Publicado: (2022)

Long-term outcomes of an esophagus-preserving chemoradiotherapy strategy for patients with endoscopically unresectable stage I thoracic esophageal squamous cell carcinoma
por: Suwa, Tatsuya, et al.
Publicado: (2021)

Recurrence patterns in patients with high-grade glioma following temozolomide-based chemoradiotherapy
por: Zhou, Xiaofeng, et al.
Publicado: (2016)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9kfq0b49j1elecdq7bkglqoal4